You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨智雲健康盤中大升近12% 引進注射用伊洛前列素溶液獲券商唱好
格隆匯 08-06 14:44

智雲健康(9955.HK)今日表現強勢,盤中曾一度衝高近12%,現報1.79港元。公司是中國最大的數字化慢病管理解決方案提供商。華安證券此前維持智雲健康“買入”評級,續看好公司的渠道資源。該行指公司宣佈成功獲得注射用伊洛前列素溶液的獨家分授權許可,將全面負責該產品在大中華區(包含中國大陸及港澳地區)的商業化運營工作。伊洛前列素是治療肺動脈高壓的有效藥物,其注射劑作為國內獨家劑型有望填補市場空白。此外,公司持續佈局慢病管理市場,穩定發展P2M戰略提升公司盈利。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account